We're working on something new at CrunchBase. Edits have been disabled for a few days, but you can still contact us for urgent changes.
Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Phone(650) 233-7877
DescriptionVenture capital Firm


Versant Ventures IV, 8/2008 $500M
Versant Venture Capital V, 10/2013 $250M


Menlo Park, USA
3000 Sand Hill Road, Bldg 4
Suite 210
Menlo Park, CA, 94025
Newport Beach, USA
450 Newport Center Drive
Suite 600
Newport Beach, CA, 92660
San Francisco, USA
1700 Owens Street
Suite 541
San Francisco, CA, 94158


Venture partner & Advisor
Venture partner & Advisor
Venture partner & Advisor
Venture partner & Advisor
Venture partner & Advisor
Venture partner & Advisor
Managing Director, Co-Founder
Managing Director, Co-Founder
Show All People


Versant Ventures

Versant Ventures is a leading healthcare-focused venture capital firm specializing in early-stage investments in medical devices, biotechnology and pharmaceuticals, healthcare services, and healthcare information technology. The firm, founded in 1999, consists of a seasoned team of twelve managing directors with more than 130 years of venture capital investing experience and more than 150 years of operating experience.

Recent Milestones


Company Date Round Size Participants
ForSight Labs 4/2014Series C$15M4
AAVLife 4/2014Series A$12M2
Sequent Medical 4/2014Series D$20M4
Holaira 4/2014Series D$42M6
RuiYi 3/2014Series B$15M6
Intuity Medical 1/2014Series F$5.5M5
Inception Sciences 12/2013Series A$10M1
Immune Design 10/2013Series C$49M6
Inceptus Medical 10/2013Series A$4.7M2
Inari Medical 10/2013Private Equity$4.71M2
Audentes Therapeutics 7/2013Series A$30M3
Veracyte 6/2013Series C$28M5
GenSight Biologics 4/2013Series A€32M4
Theraclone Sciences 3/2013Series B$8M8
Novira Therapeutics 3/2013Series A$25M7
Achaogen 3/2013Private Equity$18.9M7
Innovative Pulmonary Solutions 2/2013Series C$10M4
Glaukos 2/2013Series F$30M7
Ocular Therapeutix 1/2013Series D$23.8M4
Ceterix Orthopaedics 1/2013Series B$19.5M3
Minerva Surgical 12/2012Venture Round$20M1
CardiAQ Valve Technologies 11/2012Series B$37.3M2
Cerephex 10/2012Series A$5.92M3
Cotera 10/2012Venture Round$5.04M3
Innovative Pulmonary Solutions 9/2012Venture Round$10.6M4
ROX Medical 9/2012Venture Round$6M2
Alter-G 8/2012Series C$10M1
Intuity Medical 8/2012Partial Close$12M4
Spark Diagnostics 7/2012Venture Round$500k1
Benvenue Medical 6/2012Series D$25M4
Twelve 6/2012Venture Round$15M3
Zyga Technology 5/2012Series C$25M4
NeoVista 5/2012Partial Close$6M5
Five Prime Therapeutics 4/2012Private Equity$10M2
OpGen 3/2012Series C$17M6
Sequent Medical 3/2012Series C$26M4
Groove Biopharma 12/2011Series B$6M4
AcuFocus 11/2011Series F$65M5
Advanced ICU Care 11/2011Series D$8M4
Kythera Biopharmaceuticals 9/2011Series D$37.4M7
Intuity Medical 8/2011Series D$12M5
WaveTec Vision 5/2011Series D$15.9M4
Benvenue Medical 4/2011Series C$35.5M3
Augmenix 1/2011Debt$3M3
Synosia Therapeutics 10/2010Series C$30M7
OpGen 9/2010Series B$17M5
Okairos 9/2010Series B$20.5M2
Immune Design 7/2010Series B$32M5
Veracyte 6/2010Series B$28M4
Sequent Medical 5/2010Series B$15.6M3
Groove Biopharma. 4/2010Series A$3.9M5
Intuity Medical 1/2010Series D$64M6
Fluidigm 11/2009Venture Round$7.5M8
CymaBay Therapeutics 11/2009Venture Round$8.6M12
Augmenix 10/2009Series B$6.1M4
Flexion Therapeutics 10/2009Series A$33M3
Ocular Therapeutix 6/2009Series C$15M3
Anaphore 6/2009Series A$13M5
Clovis Oncology 5/2009Private Equity$145M7
RedBrick Health 4/2009Series C$15M4
Ambrx 4/2009Series D$10M7
Rennovia 3/2009Series A$16.3M2
LensX Lasers 3/2009Series B$22.4M3
Alter-G 1/2009Series B$8M1
Synosia Therapeutics 1/2009Series B$29M7
Cardiac Concepts 10/2008Series B$21M6
APT Pharmaceuticals 9/2008Series A$32M7
Microfabrica 9/2008Series B$22.5M6
Glaukos 8/2008Series D$35M7
Immune Design 7/2008Series A$18M3
Vaccsys 6/2008Venture Round$9M3
Kythera Biopharmaceuticals 5/2008Series C$30M9
NovaSys 5/2008Venture Round$49.5M10
Anaphore 4/2008Venture Round$8M2
Cameron Health 3/2008Series E$14M4
PhaseRx 2/2008Series A$20.2M3
Benvenue Medical 1/2008Series B$15M3
OpGen 9/2007Series A$23.6M4
CymaBay Therapeutics 4/2007Series D$32M16
Fluidigm 1/2007Series E$17M10
Synosia Therapeutics 1/2007Venture Round$32.5M4
NeoVista 12/2006Series C$41M6
Impedance Cardiology Systems 11/2006Series B$5M2
Neurotech 11/2006Series B$35M12
Achaogen 10/2006Series B$26M5
NeoVista 9/2006Series B$26M4
Kythera Biopharmaceuticals 7/2006Series B$30M6
Pathwork Diagnostics 7/2006Venture Round$11M5
MedManage Systems 4/2006Series D$10.8M4
Kythera Biopharmaceuticals 9/2005Venture Round$1M1
Five Prime Therapeutics 2/2005Venture Round$45M10
NeoGuide Systems 11/2003Series B9
Skylight Healthcare Systems 10/2002Series B5
Glaukos 9/2002Series A$10M3



  1. Versant Ventures raises $500M for life sciences investing (deals.venturebeat.com) [edit]
  2. Versant to raise $250M fifth fund (newsle.com) [edit]
  3. Versant Ventures amassing $200M fund for biotech upstarts (fiercebiotech.com) [edit]
  4. ForSight Vision5 ropes in $15M in Series C financing to develop its intraocular therapy (fiercemedicaldevices.com) [edit]
  5. AAVLife Raises $12M in Series A Financing (finsmes.com) [edit]
  6. Sequent Medical Closes $20M Series D VC Financing (finsmes.com) [edit]
  7. Holaira Raises $42M in Series D Funding (finsmes.com) [edit]
  8. RuiYi Raises $15m Series B Financing (finsmes.com) [edit]
  9. SEC (sec.gov) [edit]
  10. San Francisco’s Versant Ventures Makes Splash in Vancouver; $10 Million to Biotech Company (betakit.com) [edit]
  11. Immune Design Closes an up to $49M Series C Financing (finsmes.com) [edit]
  12. Inceptus Medical completes $4.7m Series A financing for Inari Medical (finsmes.com) [edit]
  13. Silicon Valley Venture Capital Almanac - Source [edit]
  14. Audentes Therapeutics Closes $30M Series A Financing (finsmes.com) [edit]
  15. Veracyte Completes $28 Million Series C Financing (finsmes.com) [edit]
  16. GenSight Biologics Raises €32m in a Series A Financing for Ophthalmic Gene Therapy (finance.yahoo.com) [edit]
  17. Theraclone Sciences Closes $14M in Series B and Debt Financing (finsmes.com) [edit]
  18. Novira Therapeutics Completes $25 Million Series A Financing (noviratherapeutics.com) [edit]
  19. VC Funding - Q2 2013 [edit]
  20. Holaira Raises $10M in Series C Financing (finsmes.com) [edit]
  21. Glaukos Spots $30M for Eyeball Stent, Doesn't Blink in Ivantis Rivalry (pevc.dowjones.com) [edit]
  22. Ocular Therapeutix, Inc. Closes on $23.8 Million Series D Extension (businesswire.com) [edit]
  23. Ceterix Orthopaedics Raises $19.5M in Series B Financing (finsmes.com) [edit]
  24. Minerva Surgical raises $20M (bizjournals.com) [edit]
  25. CardiAQ Raises $37.3M Series B Led by OrbiMed (pevc.dowjones.com) [edit]
  26. SEC (sec.gov) [edit]
  27. VC funding: Q4 2012 [edit]
  28. Innovative Pulmonary Raises $10.6M for COPD Therapy Trials, Names New CEO (pevc.dowjones.com) [edit]
  29. ROX Medical Grabs Another $6M for Hypertension Therapy (pevc.dowjones.com) [edit]
  30. Versant Ventures Puts Another $10M Into High-Tech Treadmill Maker Alter-G (pevc.dowjones.com) [edit]
  31. SEC (sec.gov) [edit]
  32. VC Funding: Q3 2012 [edit]
  33. Benvenue Medical Secures $25 Million Series D Financing (sacbee.com) [edit]
  34. SEC (sec.gov) [edit]
  35. Zyga Stacks Up $25M Series C To Test, Sell Joint Devices (pevc.dowjones.com) [edit]
  36. VC Funding: Q2 2012 source [edit]
  37. SEC (sec.gov) [edit]
  38. OpGen raises another $17 million in VC (bizjournals.com) [edit]
  39. Sequent Medical Announces Closing of $26.0 Million Venture Financing (marketwatch.com) [edit]
  40. Groove Biopharma Raises $6M in Series B Financing (finsmes.com) [edit]
  41. AcuFocus Closes $65M Financing (finsmes.com) [edit]
  42. Trident Capital, Inc. Invests in Advanced ICU Care® and Its ICU Performance Solutions (icumedicine.com) [edit]
  43. KYTHERA Biopharmaceuticals Closed $37.4M Series D Financing (finsmes.com) [edit]
  44. Intuity Medical Closes $12M Second Tranche of Series D Financing (finsmes.com) [edit]
  45. WaveTec Vision Closes $15.9M Series D Financing (finsmes.com) [edit]
  46. Benvenue Medical raises $35.5M (bizjournals.com) [edit]
  47. Medical device startup Augmenix infused with $3M financing (masshightech.com) [edit]
  48. Synosia Therapeutics Raises $30M in Series C Financing (synosia.com) [edit]
  49. OpGen Completes $17 Million Series B Financing (opgen.com) [edit]
  50. Italy's Okairos raises $20.5M for vaccine work (fiercebiotech.com) [edit]
  51. Immune Design Nabs $32M for Targeted Vaccines (xconomy.com) [edit]
  52. Veracyte, Inc.: Series B $28M (onbiovc.com) [edit]
  53. Sequent Medical, Inc.: Series B $15.6M (onbiovc.com) [edit]
  54. Mirina Nabs $3.9M (xconomy.com) [edit]
  55. Intuity Medical Secures $64M in Series D Financing Round (finsmes.com) [edit]
  56. Fluidigm raises another $7.5M for stem-cell analysis chips (venturebeat.com) [edit]
  57. Metabolex (Metabolex.com) [edit]
  58. Xconomy Boston (xconomy.com) [edit]
  59. Flexion garners $33M in Series A (fiercebiotech.com) [edit]
  60. I-Therapeutix, Inc.: Series C $15M (onbiovc.com) [edit]
  61. Anaphore, Inc.: Series A $13M (onbiovc.com) [edit]
  62. Clovis Oncology (Boulder, CO) an entity focused on licensing or acquiring rights to oncology compounds in all stages of clinical development (onbiovc.com) [edit]
  63. CVCA (cvca.com.cn) [edit]
  64. Ambrx, Inc.: Series D $10M (onbiovc.com) [edit]
  65. SEC (sec.gov) [edit]
  66. LensX Lasers nabs $22M for eye surgery lasers (venturebeat.com) [edit]
  67. Alter‐G secures $8 million in series B financing from Versant Ventures (alter-g.com) [edit]
  68. Synosia raises $29M for Phase II testing (fiercebiotech.com) [edit]
  69. Cardiac Concepts Raises $21 Million (equityhelpdesk.com) [edit]
  70. APT Pharmaceuticals Secures $32 Million in Series B Financing (aptbio.com) [edit]
  71. Microfabrica Secures $22.5 Million Funding to Grow its Medical Device Business (microfabrica.com) [edit]
  72. Glaukos Adds $35 Million (equityhelpdesk.com) [edit]
  73. Immune Design Aiming To Make Vaccines That Work Better in a Single Shot (xconomy.com) [edit]
  74. Vaccsys raises $9 million for vaccine research (venturebeat.com) [edit]
  75. Capital Funding Report [edit]
  76. Novasys Medical takes $49.5M for women’s medical device (venturebeat.com) [edit]
  77. April 15, 2008 - Anaphore Receives $8M In Financing (anaphoreinc.com) [edit]
  78. Defibrillator maker Cameron Health takes in $14M (venturebeat.com) [edit]
  79. Biotech Startup PhaseRx Wins $19M Pledge (biospace.com) [edit]
  80. Benvenue Medical Closes $15 Million Series B Financing (benvenuemedical.com) [edit]
  81. OpGen Announces $23.6 Million Series A Financing (opgen.com) [edit]
  82. Metabolex (Metabolex.com) [edit]
  83. Life science fluid control company, Fluidigm, raises $17M more (venturebeat.com) [edit]
  84. Neurological co. Synosis raises $32.5M (venturebeat.com) [edit]
  85. NeoVista, a co. targeting age-related macular degeneration, raises $41M (venturebeat.com) [edit]
  86. Impedance Cardiology raises $5 million (venturebeat.com) [edit]
  87. Neurotechâ„¢, Inc. Completes $35 Million Private Equity Financing (neurotechusa.com) [edit]
  88. Achaogen Closes Series B Financing (achaogen.com) [edit]
  89. NeoVista, a radiation treatment device maker, to raise $26M (venturebeat.com) [edit]
  90. KYTHERA Raises $30 Million In Series B Financing (kytherabiopharma.com) [edit]
  91. EDGAR [edit]
  92. MedManage Systems, Inc. Closes $10.75 Million Series D (biospacejobs.com) [edit]
  93. EDGAR [edit]
  94. Five Prime Therapeutics, Inc. Raises $45MM in Private Financing (fiveprime.com) [edit]
  95. Citation Needed [add]
  96. Citation Needed [add]
  97. Glaukos Receives Series A Investment From Domain Associates, LLC, Versant Ventures, And Frazier Healthcare Ventures (privco.com) [edit]
Edit This Page
Last Edited 4/16/14

Revision History RSS Picture


Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API


Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy